4 Tomorrow
Analysis
4 Tomorrow is a registered charity in United States, based in Redmond, WA. It received its IRS tax-exemption ruling in July 2020, 6 years ago. Its declared purposes cover youth development, which this site groups under children and youth development. The IRS classifies it as a publicly supported organisation (gross receipts test) under section 501(c)(3), and contributions to it are listed as tax-deductible.
In the financial year ending December 2023, 4 Tomorrow reported income of $1.6m and spending of $1.6m, spending 99% of its income. Across the 3 years on record, from December 2021 to December 2023, income grew from $729k to $1.6m (+117%), an average of +48% a year. The sharpest change came in the year to December 2022, when income rose by 272%. Over the whole period it spent 101% of the income it received.
Among 14,332 United States charities whose main cause is children and youth development and that reported income, 4 Tomorrow sits at the 90th percentile: it is larger than about 90% of them. Against every charity in United States with reported income it ranks in the 84th percentile, and in the 84th percentile within WA. Charities of a similar size with the same main cause include Dreamchasers ($1.6m), Georgia Career and Technical Instruction Inc ($1.6m) and The Pearl House Inc ($1.6m).
On its Form 990 for the period ending December 2023, revenue came from contributions and grants 0.1% and program service revenue 100% of the total. Compensation of current officers, directors and key employees was $123k (7.8% of expenses). Other salaries and wages came to $506k. At year end it held assets of $64k against liabilities of $33k, net assets of $31k. It reported 14 employees.
Income and spending
Where the income comes from
- Contributions & grants 0.1%
- Program services 100%
- Other 0.0%
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| Dreamchasers | Clarksville | $1.6m |
| Georgia Career and Technical Instruction Inc | Rome | $1.6m |
| The Pearl House Inc | Tulsa | $1.6m |
| Bioadvance | Conshohocken | $1.6m |